Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E02-07-0390 on December 7, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E02-07-0390v1
14/3/848    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kramer, K.
Right arrow Articles by Rounds, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kramer, K.
Right arrow Articles by Rounds, S.

Vol. 14, Issue 3, 848-857, March 2003

Isoprenylcysteine Carboxyl Methyltransferase Activity Modulates Endothelial Cell Apoptosis

Kristina Kramer,* Elizabeth O. Harrington,* Qing Lu, Robert Bellas, Julie Newton, Kerri L. Sheahan, and Sharon Roundsdagger

Pulmonary Vascular Biology Laboratory, Providence Veterans Affairs Medical Center, Brown Medical School, Providence, Rhode Island 02908

Extracellular ATP, adenosine (Ado), and adenosine plus homocysteine (Ado/HC) cause apoptosis of cultured pulmonary artery endothelial cells through the enhanced formation of intracellular S-adenosylhomocysteine and disruption of focal adhesion complexes. Because an increased intracellular ratio of S-adenosylhomocysteine/S-adenosylmethionine favors inhibition of methylation, we hypothesized that Ado/HC might act by inhibition of isoprenylcysteine-O-carboxyl methyltransferase (ICMT). We found that N-acetyl-S-geranylgeranyl-L-cysteine (AGGC) and N-acetyl-S-farnesyl-L-cysteine (AFC), which inhibit ICMT by competing with endogenous substrates for methylation, caused apoptosis. Transient overexpression of ICMT inhibited apoptosis caused by Ado/HC, UV light exposure, or tumor necrosis factor-alpha . Because the small GTPase, Ras, is a substrate for ICMT and may modulate apoptosis, we also hypothesized that inhibition of ICMT with Ado/HC or AGGC might cause endothelial apoptosis by altering Ras activation. We found that ICMT inhibition decreased Ras methylation and activity and the activation of the downstream signaling molecules Akt, ERK-1, and ERK-2. Furthermore, overexpression of wild-type or dominant active H-Ras blocked Ado/HC-induced apoptosis. These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and its downstream antiapoptotic signaling pathway.


* These authors contributed equally to this work.

dagger Corresponding author. E-mail address: Sharon_Rounds{at}brown.edu.


Molecular Biology of the Cell
Vol. 14, 848-857, March 2003
Copyright © 2003 by The American Society for Cell Biology



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Lu
Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L123 - L133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Purohit, M. F Abdelmalek, S. Barve, N. J Benevenga, C. H Halsted, N. Kaplowitz, K. K Kharbanda, Q.-Y. Liu, S. C Lu, C. J McClain, et al.
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Q. Lu, E. O. Harrington, J. Newton, M. Jankowich, and S. Rounds
Inhibition of ICMT Induces Endothelial Cell Apoptosis through GRP94
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 20 - 30.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Winter-Vann, R. A. Baron, W. Wong, J. dela Cruz, J. D. York, D. M. Gooden, M. O. Bergo, S. G. Young, E. J. Toone, and P. J. Casey
A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells
PNAS, March 22, 2005; 102(12): 4336 - 4341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. O. Harrington, J. Newton, N. Morin, and S. Rounds
Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1091 - L1097.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Q. Lu, E. O. Harrington, C.-M. Hai, J. Newton, M. Garber, T. Hirase, and S. Rounds
Isoprenylcysteine Carboxyl Methyltransferase Modulates Endothelial Monolayer Permeability: Involvement of RhoA Carboxyl Methylation
Circ. Res., February 20, 2004; 94(3): 306 - 315.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]